Dicerna Pharmaceutic
(DRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,544 | 29,187 | 27,614 | 56,058 | 52,943 |
| Marketable Securities | 25,002 | 40,003 | 53,031 | 38,551 | 41,096 |
| TOTAL | $59,382 | $70,672 | $81,812 | $96,141 | $95,709 |
| Non-Current Assets | |||||
| PPE Net | 2,373 | 2,466 | 2,536 | 2,684 | 2,715 |
| Investments And Advances | 0 | 0 | 0 | 0 | 13,990 |
| Other Non-Current Assets | 1,194 | 1,195 | 1,196 | 1,198 | 1,227 |
| TOTAL | $3,567 | $3,661 | $3,732 | $3,882 | $17,932 |
| Total Assets | $62,949 | $74,333 | $85,544 | $100,023 | $113,641 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,657 | 3,223 | 2,438 | 2,621 | 1,370 |
| Accrued Expenses | 6,160 | 6,090 | 4,898 | 6,380 | 7,991 |
| TOTAL | $9,817 | $9,365 | $7,364 | $9,001 | $9,361 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 52 | 28 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,817 | $9,365 | $7,364 | $9,001 | $9,361 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,753 | 20,753 | 20,726 | 20,648 | 20,593 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -241,734 | -227,558 | -211,936 | -196,243 | -180,608 |
| TOTAL | $53,132 | $64,968 | $78,180 | $91,022 | $104,280 |
| Total Liabilities And Equity | $62,949 | $74,333 | $85,544 | $100,023 | $113,641 |